-
14433-5A bpV compound that selectively inhibits PTEN (IC<sub>50</sub> = 14 nM) also inhibits the vascular endothelial PTP, PTP-&beta (IC<sub>50</sub> = 4.9 &muM), and PTP-1&betaB (IC<sub>50</sub> = 25.3 &muM) with reduced potency.
-
15438-25
Thomas Scientific
bpV(HOpic) (potassium salt, technical grade)-25 mg
Price: $359.77List Price: $399.74A bisperoxovanadium compound that selectively inhibits PTEN (IC<sub>50</sub> = 14 nM) also inhibits the vascular endothelial protein tyrosine phosphatase, PTP-&beta (IC<sub>50</sub> = 4.9 &muM), and PTP-1&betaB (IC<sub>50</sub> = 25. -
15438-5
Thomas Scientific
bpV(HOpic) (potassium salt, technical grade)-5 mg
Price: $106.02List Price: $117.80A bisperoxovanadium compound that selectively inhibits PTEN (IC<sub>50</sub> = 14 nM) also inhibits the vascular endothelial protein tyrosine phosphatase, PTP-&beta (IC<sub>50</sub> = 4.9 &muM), and PTP-1&betaB (IC<sub>50</sub> = 25. -
13331-25An inhibitor of several different PTPs, with selectivity for PTEN (IC<sub>50</sub> = 38 nM) also inhibits PTP-&beta (IC<sub>50</sub> = 343 nM), PTP-1&beta (IC<sub>50</sub> = 920 nM), and SHIP-2 activates the insulin receptor tyrosine kinase and
-
13331-5An inhibitor of several different PTPs, with selectivity for PTEN (IC<sub>50</sub> = 38 nM) also inhibits PTP-&beta (IC<sub>50</sub> = 343 nM), PTP-1&beta (IC<sub>50</sub> = 920 nM), and SHIP-2 activates the insulin receptor tyrosine kinase and
-
14434-25A bpV compound that selectivity inhibits PTEN (IC<sub>50</sub> = 31 nM) also inhibits the vascular endothelial PTP, PTP-&beta (IC<sub>50</sub> = 12.7 &muM), and PTP-1&betaB (IC<sub>50</sub> = 61 &muM) and is known to be an insulin mimetic
-
14434-5A bpV compound that selectivity inhibits PTEN (IC<sub>50</sub> = 31 nM) also inhibits the vascular endothelial PTP, PTP-&beta (IC<sub>50</sub> = 12.7 &muM), and PTP-1&betaB (IC<sub>50</sub> = 61 &muM) and is known to be an insulin mimetic
-
17403-1A potent, selective antagonist of ETB (IC<sub>50</sub> = 1.2 nM for blocking ET-1 binding to human Girardi heart cells) competitively antagonizes the vasoconstriction induced by an ETB-selective agonist on isolated rabbit pulmonary arteries.
-
17403-500A potent, selective antagonist of ETB (IC<sub>50</sub> = 1.2 nM for blocking ET-1 binding to human Girardi heart cells) competitively antagonizes the vasoconstriction induced by an ETB-selective agonist on isolated rabbit pulmonary arteries.
-
15393-10A positive allosteric modulator of the M1 mAChR dose-dependently reduces the concentration of acetylcholine required to activate M1 the effective range for potentiation is 0.1 to 100 &muM with 3 nM acetylcholine restores impairment in reversal
-
15393-25A positive allosteric modulator of the M1 mAChR dose-dependently reduces the concentration of acetylcholine required to activate M1 the effective range for potentiation is 0.1 to 100 &muM with 3 nM acetylcholine restores impairment in reversal
-
15393-5A positive allosteric modulator of the M1 mAChR dose-dependently reduces the concentration of acetylcholine required to activate M1 the effective range for potentiation is 0.1 to 100 &muM with 3 nM acetylcholine restores impairment in reversal